Menu
Skip to content

Core Facility for Quantitative Imaging and Artificial Intelligence

Core Facility for Quantitative Imaging and Artificial Intelligence

The focus of our scientific work is the development of new methods for the detection, characterization and quantification of pathological changes based on tomographic image data (computed tomography, magnetic resonance imaging). In this context, we are concerned with both the optimization of image acquisition and the development of new quantitative evaluation methods, including  artificial intelligence. As a central research group we provide a framework for workflow-optimized image analysis in clinical research and also provide a platform for the implementation of project-specific software (rapid prototyping).

PD Dr.-Ing. Alois Martin Sprinkart
Tel.: +49 228 287 38531
E-Mail: Enable JavaScript to view protected content.

PD Dr. rer. nat. Wolfgang Block
Tel.: +49 228 287 11835
E-Mail: Enable JavaScript to view protected content.

Sebastian Nowak, M.Sc.
Tel.: +49 228 287 16651
E-Mail: Enable JavaScript to view protected content.

Unsere Webseite verwendet Cookies.

These include essential cookies that are necessary for the operation of the site, as well as others that are used only for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, not all functions of the website may be available.

Unsere Webseite verwendet Cookies.

These include essential cookies that are necessary for the operation of the site, as well as others that are used only for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, not all functions of the website may be available.

Your cookie preferences have been saved.

Information gemäß § 6 Medizinprodukte-Betreiberverordnung "Beauftragter für Medizinproduktesicherheit"

Sehr geehrte Damen und Herren,

gemäß § 6 Medizinprodukte-Betreiberverordnung steht Ihnen das Universitätsklinikum Bonn im Zusammenhang mit Meldungen über Risiken von Medizinprodukten, Informationen zu Rückrufen oder Warn- und Sicherheitshinweisen sowie bei der Umsetzung von notwendigen korrektiven Maßnahmen unter folgender E-Mailadresse zur Verfügung: Enable JavaScript to view protected content.

Diese E-Mailadresse richtet sich vorzugsweise an Kontaktpersonen von Behörden, Herstellern und Vertreibern von Medizinprodukten.